Category: Recovery

Temporal trajectories of COVID-19 symptoms in adults with 22 months follow-up in a prospective cohort study in Norway

Posted on | Posted on John Murphy | Leave a Comment on Temporal trajectories of COVID-19 symptoms in adults with 22 months follow-up in a prospective cohort study in Norway

Merete Ellingjord-Dale, Anders Nygaard, Nathalie C Støer, et. al. BioRx 05/2024 Abstract Objectives We aimed to describe the trajectories of cognitive and physical symptoms before, during, and after a positive- or negative SARS-CoV-2 test and in untested controls. Design A prospective cohort study. Setting Norway, 27 March 2020 to 6 July 2022 Participants A total of 146 065 volunteers were recruited. Of these, 120 […]

Pandemic health consequences: Grasping the long COVID tail

Posted on | Posted on John Murphy | Leave a Comment on Pandemic health consequences: Grasping the long COVID tail

Authors: Kieran L. Quinn , Chaim M. Bell Published: January 25, 2022 Emerging evidence suggests that approximately 10% of people who survive Coronavirus Disease 2019 (COVID-19) will have lingering symptoms that negatively affect their quality of life, ability to work, and function [1,2]. This important group of people with the post-COVID-19 condition may seem small in comparison […]

Colchicine could cut COVID-19 deaths – Israeli scientist

Posted on | Posted on John Murphy | Leave a Comment on Colchicine could cut COVID-19 deaths – Israeli scientist

Authors: By MAAYAN JAFFE-HOFFMAN Published: DECEMBER 14, 2021 17:37 An ancient Greek drug derived from the saffron plant could improve the treatment of people with severe COVID-19 and reduce the COVID mortality rate by as much as 50%, according to a report published earlier this month in the European Journal of Internal Medicine by an Israeli researcher from the Hebrew University of […]

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Posted on | Posted on John Murphy | Leave a Comment on Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Julia Hippisley-Cox1, Duncan Young2,3, Carol Coupland4, Keith M Channon5, Pui San Tan6, David A Harrison7, Kathryn Rowan8,  Paul Aveyard6, Ian D Pavord9, Peter J Watkinson5,10 Correspondence to Prof Julia Hippisley-Cox, Primary Care Health Sciences, University of Oxford, Oxford OX1  Abstract Background  There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied whether […]

How to combat ‘COVID fatigue’: Medical experts on what works — and doesn’t

Posted on | Posted on John Murphy | Leave a Comment on How to combat ‘COVID fatigue’: Medical experts on what works — and doesn’t

Authors: Meredith Deliso “Throughout pandemics, the psychological footprint is often way bigger than the medical footprint,” Dr. Claude Mellins, a medical psychologist who co-leads a pandemic initiative called CopeColumbia for the Columbia University Irving Medical Center community, told ABC News. One of the challenges is the pandemic makes it hard to turn to our normal […]